Sigma ligands stimulate GTPase activity in mouse prefrontal membranes: Evidence for the existence of metabotropic sigma receptor

Neuroscience Letters

Volumn 233, Issue 2-3, 1997, Pages 141-144

  Tokuyama, Shogo ^a   Hirata, Kinya ^a   Ide, Asuka ^a   Ueda, Hiroshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

G protein; GTPase; Metabotropic receptor; Sigma receptor; Signal transduction

Indexed keywords

GUANOSINE TRIPHOSPHATASE; METABOTROPIC RECEPTOR; SIGMA OPIATE RECEPTOR;

ANIMAL TISSUE; ARTICLE; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; MALE; MOUSE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RECEPTOR DENSITY; SECOND MESSENGER; TISSUE DISTRIBUTION;

ANIMALS; GTP PHOSPHOHYDROLASES; LIGANDS; LOGISTIC MODELS; MALE; MEMBRANES; MICE; MICE, INBRED STRAINS; PREFRONTAL CORTEX; RECEPTORS, SIGMA; STIMULATION, CHEMICAL;

EID: 0343471425     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00657-5     Document Type: Article

References (22)

1. Clissold, D.B., Pontecorvo, M.J., Jones, B.E., Abreu, M.E., Karbon, E.W., Erickson, R.H., Natalie, K.J. Jr., Borosky, S., Hartman, T., Mansbach, R.S., Balster, R.L., Ferkany, J.W. and Enna, S.J., NPC 16377, a potent and selective σ-ligand. II. Behavioral and neuroprotective profile, J. Pharmacol. Exp. Ther., 265 (1993) 876-886.
2. Contreras, P.C., Contreras, M.L., O'donohue, T.L. and Lair, C.C., Biochemical and behavioral effects of sigma and PCP ligands, Synapse, 2 (1988) 240-243.
3. Haertzen, C.A., Subjective effects of narcotic antagonists cyclazocine and nalorphine on the addiction research inventory (ARCI), Psychopharmacologia, 18 (1970) 366-377.
4. Hanner, M., Moebius, F.F., Flandorfer, A., Knaus, H.-G., Striessing, J., Kempner, E. and Glossmann, H., Purification, molecular cloning, and expression of the mammalian sigmarbinding site, Proc. Natl. Acad. Sci. USA, 93 (1996) 8072-8077.
5. Itzhak, Y., Multiple affinity binding states of the σ receptor: effects of GTP-binding protein modifying agents, Mol. Pharmacol., 36 (1989) 512-517.
6. Itzhak, Y. and Khouri, M., Regulation of the binding of sigma and phencyclidine (PCP) receptor ligands in rat brain membranes by guanine nucleotides and ions, Neurosci. Lett., 85 (1988) 147-152.
7. Keats, A.S. and Telford, J., Narcotic antagonists as analgesics, Adv. Chem. Ser., 45 (1964) 170-176.
8. Martin, W.R., Eades, G.G., Thompson, J.A., Huppier, R.E. and Gilbert, P.E., The effects of morphine- and narolphine-like drugs in the nondependent and morphine-dependent chronic spinal dog, J. Pharmacol. Exp. Ther., 197 (1976) 517-532.
9. Matsuno, K., Matsunaga, K. and Mita, S., Increase of extracellular acetylcholine level in rat frontal cortex induced by (+)N-allylnormetazocine as measured by brain microdialysis, Brain Res., 575 (1992) 315-319.
10. 1 receptor agonist, Eur. J. Pharmacol., 406 (1996) 271-279.
11. Nabeshima, T. and Okuyama, S., Physiological function of sigma receptors: central pharmacological effects of sigma ligands, Jpn. J. Psychopharmacol., 14 (1994) 51-76.
12. Okuyama, S., Imagawa, Y., Sakagawa, T., Nakazato, A., Yamaguchi, K., Katoh, M., Yamada, S., Araki, H. and Otomo, S., NE-100, a novel sigma receptor ligand: effect on phencyclidine-induced behaviors in rats, dogs and monkeys, Life Sci., 55 (1994) 133-138.
13. Quirion, R., Bowen, W., Itzhak, Y., Junien, J.L., Musacchio, J.M., Rothman, R.B., Su, T.-P., Tarn, S.W. and Taylor, D.P., A proposal for the classification of sigma binding sites, Trends Pharmacol. Sci., 13 (1992) 85-86.
14. 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats, Eur. J. Pharmacol., 315 (1996) 1-10.
15. Taylor, D.P. and Dekleva, J., Potential antipsychotic BMY-14802 selectively binds to sigma sites, Drug Dev. Res., 11 (1987) 65-70.
16. Ueda, H., Misawa, H., Katada, T., Ui, M., Takagi, H. and Satoh, M., Functional reconstitution of purified Gi and Go with μ-opioid receptors in guinea pig striatal membranes pretreated with micromolar concentrations of N-ethylmaleimide, J. Neurochem., 54 (1990) 841-848.
17. Ueda, H., Yoshihara, Y., Misawa, H., Fukushima, N., Katada, T., Ui, M., Satoh, M. and Takagi, H., The kyotorphin (tyrosine-arginine) receptor and a selective reconstitution with purified Gi, measured with GTPase and phospholipase C assays, J. Biol. Chem., 264 (1989) 3732-3741.
18. Vaupel, D.B., Naltrexone fails to antagonize the sigma effects of PCP and SKF10.047 in the dog, Eur. J. Pharmacol., 92 (1983) 269-274.
19. Walker, J.M., Bowen, W.D., Walker, F.O., Matsumoto, R.R., De Costa, B. and Rice, K.C., Sigma receptors: biology and function, Pharmacol. Rev., 42 (1990) 366-402.
20. Walker, J.M., Matsumoto, R.R., Bowen, W.D., Gans, D.L., Jones, K.D. and Walker, F.O., Evidence for a role of haloperidol-sensitive σ-'opiate' receptors in the motor effects of antipsychotic drugs, Neurology, 38 (1988) 961-965.
21. Wettstein, J.G., Roman, F.J., Rocher, M.-N. and Junien, J.-L., Effects of sigma receptor ligands on schedule-controlled behavior of rats: relation to sigma and PCP receptor binding affinity, Psychopharmacology, 104 (1991) 157-163.
22. 3H]TCP binding to intact primary cultured neuronal cells, Life Sci., 56 (1995) 39-43.